Topic: blood clots

J&J launches biologic protein spray for sealing surgical bleeds

by Conor Hale

Tuesday, December 3, 2019

The first product from Ethicon's collaboration with Grifols, the Vistaseal spray combines two clotting agents to control surgical bleeds.

FDA expedites Fresenius dialysis machine made to prevent clots

by Conor Hale

Monday, October 28, 2019

Fresenius Medical Care received an FDA breakthrough designation for a new dialysis machine designed to prevent blood clots using an internal polymer.

Anthos Therapeutics

by Amirah Al Idrus

Launched in February with $250 million and a midphase heart disease drug from Novartis, Anthos’ sizable war chest means it can run large cardiovascular studies that are often beyond the reach of young biotech companies.

FDA clears HemoSonics' rapid blood coagulation tester

by Conor Hale

Friday, April 12, 2019

HemoSonics’ point-of-care diagnostic for a patient’s coagulation status works within 15 minutes, to respond to critical bleeding situations.

PhaseBio eyes phase 2 for Brilinta-reversing drug

by Amirah Al Idrus

Tuesday, March 19, 2019

Phase 1 data for PhaseBio's Brilinta reversal agent showed the drug quickly reversed the effects of Brilinta without causing serious side effects.

Using ‘decoy’ platelets to stem blood clots and cancer

by Angus Liu

Wednesday, February 13, 2019

A team led by the Wyss Institute has created reversible platelets that they say may not only reduce blood clots but might also prevent cancer from spreading.

Inari raises $27M to commercialize clot removal devices

by Nick Paul Taylor

Friday, March 30, 2018

With Inari's commercial opportunities increasing, it has pulled in its biggest round to date to fuel a sales and marketing push.

Shire gets injunction against hemophilia rival Roche

by Nick Paul Taylor

Monday, July 10, 2017

Shire has obtained a preliminary injunction to stop Roche spreading “inaccurate and misleading” statements about clinical trial data.

Snake venom-based antiplatelet drug could cut bleeding risk

by Amirah Al Idrus

Thursday, June 8, 2017

A new snake venom-based antiplatelet drug could avoid excessive bleeding associated with other antiplatelet meds.

Sonavex raises $3M for ultrasound blood-clot detector

by Amirah Al Idrus

Monday, April 24, 2017

Johns Hopkins spinout Sonavex reeled in $3 million, including $2.2 million from the first close of its Series A round for its ultrasound blood-clot detector.

GET THE NEWSLETTER

Subscribe to FierceBiotech to get industry news and updates delivered to your inbox.